Global Cancer Immunotherapies Market 2016-2020
Single User License - $2500 Site User License - $3000 Corporate User License - $4000 Publication Date - Apr 2016 Pages - 121 To know more details, email to debora@reportstack.com
Contact: debora@reportstack.com Reportstack Market Research
Summary
• Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market. • This report forecasts the global cancer immunotherapies market is expected to grow at a CAGR of 15.17% during the period 2016-2020.
Contact: debora@reportstack.com Reportstack Market Research
Key vendors
• Amgen • Bristol-Myers Squibb • F. Hoffmann-La Roche • GlaxoSmithKline • Merck • Takeda Pharmaceuticals
Contact: debora@reportstack.com Reportstack Market Research
Other Prominent Vendors • AbbVie • ADC Therapeutics • Agensys • Astellas • AstraZeneca • Bayer • Biogen,e.t.c..
Contact: debora@reportstack.com Reportstack Market Research
Key Questions Answered in this Report • What will the market size be in 2018 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors?
Contact: debora@reportstack.com Reportstack Market Research
If you are interested...
Contact : Debora White Email: debora@reportstack.com Ph:+1-888-789-6604 http://www.reportstack.com
Contact: debora@reportstack.com Reportstack Market Research